[04/06/22]
Posted on April 6, 2022 in Health Law News, Litigation Analysis
Published by: Hall Render
Recently, the Seventh Circuit, in Proctor v. Safeway, Inc., clarified what it means to act with reckless disregard in respect to claims brought under the False Claims Act (“FCA”). __ F.4th __, No. 3:11-CV-3406, 2022 WL 1012256, (7th Cir. 2022). In doing so, the court stated that authoritative guidance must be truly authoritative in... READ MORE
Tags: Authoritative Guidance, False Claims Act, FCA, Proctor v. Safeway, Safeco Ins. Co. of America v. Burr, Seventh Circuit Court, United States ex. rel. Schutte v. SuperValu Inc.
[03/21/22]
Posted on March 21, 2022 in False Claims Act Defense, Health Law News
Published by: Hall Render
A federal district court affirmed this guidance in a careful analysis of the attorney-client privilege and its application to protect separate legal entities within a larger corporate structure. Affirming that member entities are not treated as “one client,” the Court in U.S. ex rel Behnke v. CVS Caremark Corp., et al. denied a whistleblower’s... READ MORE
Tags: attorney-client privilege, et al., False Claims Act, FCA, U.S. ex rel Behnke v. CVS Caremark Corp., Whistleblowers
[11/20/20]
Posted on November 20, 2020 in False Claims Act Defense
Published by: Hall Render
In health care, actions under the False Claims Act (“FCA”) typically allege conduct that is knowingly in violation of one or more of Medicare’s conditions of payment—part of an amorphous contract between a government agency and a provider—that results in a fraudulently obtained overpayment to the provider for services rendered. Last week, the Ninth... READ MORE
Tags: False Claims Act, FCA, Office Depot Inc. v. AIG Specialty Insurance Company, Standard Liability Policy
[09/02/20]
Posted on September 2, 2020 in Health Law News, Litigation Analysis
Published by: Hall Render
The United States Court of Appeals, Eleventh Circuit, recently issued an opinion reaffirming the need for counsel in qui tam cases under the False Claims Act (“FCA”). In particular, pro se plaintiffs, or individuals proceeding without attorney representation, filed suit against multiple defendants alleging qui tam claims under the FCA as well as 21... READ MORE
Tags: False Claims Act, FCA, qui tam
[07/29/20]
Posted on July 29, 2020 in Health Law News
Published by: Hall Render
On July 8, 2020, the Department of Justice announced it settled a qui tam action[1] involving alleged violations of the federal and state False Claims Act (“FCA”) for $72.3 million against an Oklahoma surgical specialty hospital, its managers, a physician group and two individual physicians. Part of the factual allegations underpinning the FCA claims... READ MORE
Tags: Anti-Kickback Statute, False Claims Act, FCA, Health Care Real Estate, qui tam, Stark law
[07/01/20]
Posted on July 1, 2020 in False Claims Act Defense, Health Law News
Published by: Hall Render
On June 19, 2020, the Department of Justice (the “DOJ”) announced its Final Rule[1] increasing the penalties assessable under the False Claims Act (“FCA”). The DOJ raised the minimum penalty for a single false claim from $11,181 to $11,665; the maximum penalty from $22,363 to $23,331. Under the False Claims Act,[2] any person who... READ MORE
Tags: DOJ, False Claims Act, FCA, penalties
[04/02/20]
Posted on April 2, 2020 in False Claims Act Defense
Published by: Hall Render
An accepted doctrine of FCA pleading requires whistleblowers or the Government to assert an “objective falsehood” in their complaints. Last week, the Ninth Circuit nixed the requirement. The Ninth Circuit reversed a district court’s dismissal tied to a failure to plead an objective falsehood under FCA. The Court held that whistleblowers or the Government... READ MORE
Tags: FCA, whistleblower
[03/25/20]
Posted on March 25, 2020 in False Claims Act Defense
Published by: Hall Render
The Southern District of Indiana recently held that a whistleblower must present sufficient evidence to support each alleged false claim, not just one, to survive summary judgment.[1] This holding is a win for FCA defendants that deal in a high volume of claims submitted to the government—like hospitals—and requires whistleblowers to identify every claim... READ MORE
Tags: False Claims Act, FCA, whistleblower
[03/24/20]
Posted on March 24, 2020 in False Claims Act Defense
Published by: Hall Render
Earlier this week, the Second Circuit in Vierczhalek v. MedImmune, Inc.[1] affirmed the dismissal of a relator’s amended complaint, finding she was not an “original source” of new allegations that piggybacked on a public disclosure. Facts of the Case Relator Susan Vierczhalek, M.D., filed a qui tam action in 2009 alleging that drug manufacturer... READ MORE
Tags: False Claims Act, FCA
[03/05/20]
Posted on March 5, 2020 in False Claims Act Defense
Published by: Hall Render
In a matter of first impression, the Third Circuit yesterday held that conflicting medical opinions can create a genuine dispute of material fact as to the element of falsity in a False Claims Act action.[1] Facts of the Case In U.S. v. Care Alternatives, relators alleged that Care Alternatives, a hospice facility, “admitted patients... READ MORE
Tags: False Claims Act, FCA